BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ewing E, Kular L, Fernandes SJ, Karathanasis N, Lagani V, Ruhrmann S, Tsamardinos I, Tegner J, Piehl F, Gomez-Cabrero D, Jagodic M. Combining evidence from four immune cell types identifies DNA methylation patterns that implicate functionally distinct pathways during Multiple Sclerosis progression. EBioMedicine 2019;43:411-23. [PMID: 31053557 DOI: 10.1016/j.ebiom.2019.04.042] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Bingen JM, Clark LV, Band MR, Munzir I, Carrithers MD. Differential DNA methylation associated with multiple sclerosis and disease modifying treatments in an underrepresented minority population. Front Genet 2022;13:1058817. [PMID: 36685876 DOI: 10.3389/fgene.2022.1058817] [Reference Citation Analysis]
2 van den Hove D, Vanmierlo T, Koulousakis P, Tiane A, Hellings N, Prickaerts J. A perspective on causality assessment in epigenetic research on neurodegenerative disorders. Neural Regen Res 2023;18:331. [DOI: 10.4103/1673-5374.343898] [Reference Citation Analysis]
3 Klein K. The Role of Epigenetics in Autoimmune Disorders. Handbook of Epigenetics 2023. [DOI: 10.1016/b978-0-323-91909-8.00004-9] [Reference Citation Analysis]
4 Campagna MP, Xavier A, Lea RA, Stankovich J, Maltby VE, Butzkueven H, Lechner-Scott J, Scott RJ, Jokubaitis VG. Whole-blood methylation signatures are associated with and accurately classify multiple sclerosis disease severity. Clin Epigenetics 2022;14:194. [PMID: 36585691 DOI: 10.1186/s13148-022-01397-2] [Reference Citation Analysis]
5 Needhamsen M, Khoonsari PE, Zheleznyakova GY, Piket E, Hagemann-jensen M, Han Y, Gierlich J, Ekman D, Jagodic M. Integration of small RNAs from plasma and cerebrospinal fluid for classification of multiple sclerosis. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.1042483] [Reference Citation Analysis]
6 Xiao F, Rui K, Shi X, Wu H, Cai X, Lui KO, Lu Q, Ballestar E, Tian J, Zou H, Lu L. Epigenetic regulation of B cells and its role in autoimmune pathogenesis. Cell Mol Immunol 2022;19:1215-34. [PMID: 36220996 DOI: 10.1038/s41423-022-00933-7] [Reference Citation Analysis]
7 Olstad EW, Nordeng HME, Sandve GK, Lyle R, Gervin K. Low reliability of DNA methylation across Illumina Infinium platforms in cord blood: implications for replication studies and meta-analyses of prenatal exposures. Clin Epigenet 2022;14. [DOI: 10.1186/s13148-022-01299-3] [Reference Citation Analysis]
8 Yin Y, Xie Z, Chen D, Guo H, Han M, Zhu Z, Bi J. Integrated investigation of DNA methylation, gene expression and immune cell population revealed immune cell infiltration associated with atherosclerotic plaque formation. BMC Med Genomics 2022;15:108. [PMID: 35534881 DOI: 10.1186/s12920-022-01259-z] [Reference Citation Analysis]
9 Pahlevan Kakhki M, Starvaggi Cucuzza C, Gyllenberg A, Badam TVS, Liu Y, Boddul S, James T, Wermeling F, Gustafsson M, Casaccia P, Kockum I, Hillert J, Olsson T, Kular L, Jagodic M. Implication of DNA methylation changes at chromosome 1q21.1 in the brain pathology of Primary Progressive Multiple Sclerosis.. [DOI: 10.1101/2022.05.06.22274611] [Reference Citation Analysis]
10 Campagna MP, Xavier A, Stankovich J, Maltby V, Slee M, Kilpatrick T, Scott RJ, Butzkueven H, Lechner-scott J, Lea R, Jokubaitis V. Birth history is associated with whole-blood and T-cell methylation patterns in relapse onset multiple sclerosis.. [DOI: 10.1101/2022.03.24.22272917] [Reference Citation Analysis]
11 Kiselev I, Danilova L, Baulina N, Baturina O, Kabilov M, Boyko A, Kulakova O, Favorova O. Genome-wide DNA methylation profiling identifies epigenetic changes in CD4+ and CD14+ cells of multiple sclerosis patients. Mult Scler Relat Disord 2022;60:103714. [PMID: 35245816 DOI: 10.1016/j.msard.2022.103714] [Reference Citation Analysis]
12 Perdaens O, van Pesch V. Molecular Mechanisms of Immunosenescene and Inflammaging: Relevance to the Immunopathogenesis and Treatment of Multiple Sclerosis. Front Neurol 2022;12:811518. [DOI: 10.3389/fneur.2021.811518] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Ye F, Dai Y, Wang T, Liang J, Wu X, Lan K, Sheng W. Trans-omics analyses revealed key epigenetic genes associated with overall survival in secondary progressive multiple sclerosis. J Neuroimmunol 2022;364:577809. [PMID: 35026432 DOI: 10.1016/j.jneuroim.2022.577809] [Reference Citation Analysis]
14 Ma Q, Caillier SJ, Muzic S, Wilson MR, Henry RG, Cree BAC, Hauser SL, Didonna A, Oksenberg JR; University of California San Francisco MS-EPIC Team. Specific hypomethylation programs underpin B cell activation in early multiple sclerosis. Proc Natl Acad Sci U S A 2021;118:e2111920118. [PMID: 34911760 DOI: 10.1073/pnas.2111920118] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
15 Fernandes SJ, Ericsson M, Khademi M, Jagodic M, Olsson T, Gomez-Cabrero D, Kockum I, Tegnér J. Deep characterization of paired chromatin and transcriptomes in four immune cell types from multiple sclerosis patients. Epigenomics 2021;13:1607-18. [PMID: 34676774 DOI: 10.2217/epi-2021-0205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Maltby VE, Lea RA, Monif M, Fabis-Pedrini MJ, Buzzard K, Kalincik T, Kermode AG, Taylor B, Hodgkinson S, McCombe P, Butzkueven H, Barnett M, Lechner-Scott J. Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study). JMIR Res Protoc 2021;10:e24969. [PMID: 34665152 DOI: 10.2196/24969] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Yang M, Yi P, Jiang J, Zhao M, Wu H, Lu Q. Dysregulated translational factors and epigenetic regulations orchestrate in B cells contributing to autoimmune diseases. Int Rev Immunol 2023;42:1-25. [PMID: 34445929 DOI: 10.1080/08830185.2021.1964498] [Reference Citation Analysis]
18 Savinetti I, Papagna A, Foti M. Human Monocytes Plasticity in Neurodegeneration. Biomedicines 2021;9:717. [PMID: 34201693 DOI: 10.3390/biomedicines9070717] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Diniz SN, da Silva CF, de Almeida IT, da Silva Costa FE, de Oliveira EML. INFβ treatment affects global DNA methylation in monocytes of patients with multiple sclerosis. J Neuroimmunol 2021;355:577563. [PMID: 33853016 DOI: 10.1016/j.jneuroim.2021.577563] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
20 Kiselev IS, Kulakova OG, Boyko AN, Favorova OO. DNA Methylation As an Epigenetic Mechanism in the Development of Multiple Sclerosis. Acta Naturae 2021;13:45-57. [PMID: 34377555 DOI: 10.32607/actanaturae.11043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Planell N, Lagani V, Sebastian-Leon P, van der Kloet F, Ewing E, Karathanasis N, Urdangarin A, Arozarena I, Jagodic M, Tsamardinos I, Tarazona S, Conesa A, Tegner J, Gomez-Cabrero D. STATegra: Multi-Omics Data Integration - A Conceptual Scheme With a Bioinformatics Pipeline. Front Genet 2021;12:620453. [PMID: 33747045 DOI: 10.3389/fgene.2021.620453] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
22 Yang H, Chen Y, Xu W, Shao M, Deng J, Xu S, Gao X, Guan S, Wang J, Xu S, Shuai Z, Pan F. Epigenetics of ankylosing spondylitis: Recent developments. Int J Rheum Dis 2021;24:487-93. [PMID: 33608999 DOI: 10.1111/1756-185X.14080] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
23 Baulina N, Kiselev I, Favorova O. Imprinted Genes and Multiple Sclerosis: What Do We Know? Int J Mol Sci 2021;22:1346. [PMID: 33572862 DOI: 10.3390/ijms22031346] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Morante-Palacios O, Fondelli F, Ballestar E, Martínez-Cáceres EM. Tolerogenic Dendritic Cells in Autoimmunity and Inflammatory Diseases. Trends Immunol 2021;42:59-75. [PMID: 33293219 DOI: 10.1016/j.it.2020.11.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 11.3] [Reference Citation Analysis]
25 Zouali M. DNA methylation signatures of autoimmune diseases in human B lymphocytes. Clin Immunol 2021;222:108622. [PMID: 33188932 DOI: 10.1016/j.clim.2020.108622] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
26 Maltby VE, Lea RA, Monif M, Fabis-pedrini MJ, Buzzard K, Kalincik T, Kermode AG, Taylor B, Hodgkinson S, Mccombe P, Butzkueven H, Barnett M, Lechner-scott J. Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study) (Preprint).. [DOI: 10.2196/preprints.24969] [Reference Citation Analysis]
27 Ewing E, Planell-Picola N, Jagodic M, Gomez-Cabrero D. GeneSetCluster: a tool for summarizing and integrating gene-set analysis results. BMC Bioinformatics 2020;21:443. [PMID: 33028195 DOI: 10.1186/s12859-020-03784-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
28 Ringh MV, Hagemann-Jensen M, Needhamsen M, Kullberg S, Wahlström J, Grunewald J, Brynedal B, Jagodic M, Ekström TJ, Öckinger J, Kular L. Methylome and transcriptome signature of bronchoalveolar cells from multiple sclerosis patients in relation to smoking. Mult Scler 2021;27:1014-26. [PMID: 32729352 DOI: 10.1177/1352458520943768] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
29 Xu H, Shen Q, Fan B, Xi C, Wang L. Effectiveness of a combination therapy of traditional Chinese medicine and CO 2 laser treatment for condyloma acuminatum. J Med Virol 2020;92:3889-94. [DOI: 10.1002/jmv.25923] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Kular L, Jagodic M. Epigenetic insights into multiple sclerosis disease progression. J Intern Med 2020;288:82-102. [DOI: 10.1111/joim.13045] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
31 Hudon Thibeault AA, Laprise C. Cell-Specific DNA Methylation Signatures in Asthma. Genes (Basel) 2019;10:E932. [PMID: 31731604 DOI: 10.3390/genes10110932] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
32 Acosta-Ampudia Y, Monsalve DM, Ramírez-Santana C. Identifying the culprits in neurological autoimmune diseases. J Transl Autoimmun 2019;2:100015. [PMID: 32743503 DOI: 10.1016/j.jtauto.2019.100015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
33 Dehghanzad R, Pahlevan Kakhki M, Alikhah A, Sahraian MA, Behmanesh M. The Putative Association of TOB1-AS1 Long Non-coding RNA with Immune Tolerance: A Study on Multiple Sclerosis Patients. Neuromolecular Med 2020;22:100-10. [PMID: 31482275 DOI: 10.1007/s12017-019-08567-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]